Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal.

B. Flan,S. Arrabal
DOI: https://doi.org/10.1016/J.TRACLI.2007.04.008
IF: 2.126
2007-05-01
Transfusion Clinique et Biologique
Abstract:
What problem does this paper attempt to address?